CN109045186B - 一种消痔散及其制备方法 - Google Patents
一种消痔散及其制备方法 Download PDFInfo
- Publication number
- CN109045186B CN109045186B CN201811083037.XA CN201811083037A CN109045186B CN 109045186 B CN109045186 B CN 109045186B CN 201811083037 A CN201811083037 A CN 201811083037A CN 109045186 B CN109045186 B CN 109045186B
- Authority
- CN
- China
- Prior art keywords
- parts
- hemorrhoid
- eliminating powder
- eliminating
- hemorrhoids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000014617 hemorrhoid Diseases 0.000 title claims abstract description 138
- 239000000843 powder Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 34
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 30
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 25
- 229940116229 borneol Drugs 0.000 claims abstract description 25
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 25
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 24
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 17
- 241000219784 Sophora Species 0.000 claims abstract description 16
- 230000008569 process Effects 0.000 claims abstract description 11
- 238000001035 drying Methods 0.000 claims description 41
- 238000000227 grinding Methods 0.000 claims description 34
- 239000011812 mixed powder Substances 0.000 claims description 27
- 238000002156 mixing Methods 0.000 claims description 27
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 17
- 239000010495 camellia oil Substances 0.000 claims description 14
- 102000002322 Egg Proteins Human genes 0.000 claims description 12
- 108010000912 Egg Proteins Proteins 0.000 claims description 12
- 241000628997 Flos Species 0.000 claims description 12
- 240000001398 Typha domingensis Species 0.000 claims description 12
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims description 11
- 244000236658 Paeonia lactiflora Species 0.000 claims description 11
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims description 11
- 235000014103 egg white Nutrition 0.000 claims description 11
- 210000000969 egg white Anatomy 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 9
- 238000005286 illumination Methods 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- 230000007480 spreading Effects 0.000 claims description 9
- 238000003892 spreading Methods 0.000 claims description 9
- 238000003756 stirring Methods 0.000 claims description 9
- 239000002352 surface water Substances 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 239000003814 drug Substances 0.000 abstract description 37
- 230000000694 effects Effects 0.000 abstract description 34
- 208000002193 Pain Diseases 0.000 abstract description 29
- 230000036407 pain Effects 0.000 abstract description 29
- 230000000740 bleeding effect Effects 0.000 abstract description 16
- 229940079593 drug Drugs 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 10
- 230000004044 response Effects 0.000 abstract description 5
- 230000008029 eradication Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 28
- 210000004369 blood Anatomy 0.000 description 28
- 208000032843 Hemorrhage Diseases 0.000 description 18
- 230000008961 swelling Effects 0.000 description 10
- 208000024891 symptom Diseases 0.000 description 10
- 206010042674 Swelling Diseases 0.000 description 9
- 244000269722 Thea sinensis Species 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 206010010904 Convulsion Diseases 0.000 description 7
- 208000001840 Dandruff Diseases 0.000 description 7
- 240000007472 Leucaena leucocephala Species 0.000 description 7
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 7
- 230000036461 convulsion Effects 0.000 description 7
- 240000001548 Camellia japonica Species 0.000 description 6
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 6
- 210000000436 anus Anatomy 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 230000007812 deficiency Effects 0.000 description 6
- 208000035861 hematochezia Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 5
- 235000018597 common camellia Nutrition 0.000 description 5
- 230000013872 defecation Effects 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 201000007772 internal hemorrhoid Diseases 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 description 5
- 241000526900 Camellia oleifera Species 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000034507 Haematemesis Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 208000003251 Pruritus Diseases 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000002429 large intestine Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010071 Coma Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 240000003152 Rhus chinensis Species 0.000 description 3
- 235000014220 Rhus chinensis Nutrition 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 206010002482 Angiosclerosis Diseases 0.000 description 2
- 241000205585 Aquilegia canadensis Species 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000112528 Ligusticum striatum Species 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 240000001949 Taraxacum officinale Species 0.000 description 2
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 2
- 210000002255 anal canal Anatomy 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 229910021538 borax Inorganic materials 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000010339 dilation Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 206010029410 night sweats Diseases 0.000 description 2
- 230000036565 night sweats Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- -1 ruta rutaecarpa Chemical compound 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 239000004328 sodium tetraborate Substances 0.000 description 2
- 235000010339 sodium tetraborate Nutrition 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- JJPWJEGNCRGGGA-UHFFFAOYSA-N 4-[[2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]acetyl]amino]benzoic acid Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)NC1=CC=C(C(=O)O)C=C1 JJPWJEGNCRGGGA-UHFFFAOYSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000307697 Agrimonia eupatoria Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 208000016583 Anus disease Diseases 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 235000006226 Areca catechu Nutrition 0.000 description 1
- 235000014290 Artemisia anomala Nutrition 0.000 description 1
- 241000123844 Artemisia anomala Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 240000000572 Blumea balsamifera Species 0.000 description 1
- 206010005913 Body tinea Diseases 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- 206010007191 Capillary fragility Diseases 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000005787 Cistanche Species 0.000 description 1
- 208000002881 Colic Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 241000218176 Corydalis Species 0.000 description 1
- 241000244987 Daiswa polyphylla Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 235000008375 Decussocarpus nagi Nutrition 0.000 description 1
- 240000005636 Dryobalanops aromatica Species 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 241000935235 Fritillaria meleagris Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 244000153234 Hibiscus abelmoschus Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020741 Hyperpyrexia Diseases 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 244000132436 Myrica rubra Species 0.000 description 1
- 235000014631 Myrica rubra Nutrition 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001505010 Onychostoma Species 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 241001106477 Paeoniaceae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 240000004064 Poterium sanguisorba Species 0.000 description 1
- 235000008291 Poterium sanguisorba Nutrition 0.000 description 1
- 241000283080 Proboscidea <mammal> Species 0.000 description 1
- 206010036772 Proctalgia Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 201000002154 Pterygium Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 208000015815 Rectal disease Diseases 0.000 description 1
- 206010038910 Retinitis Diseases 0.000 description 1
- 241000282806 Rhinoceros Species 0.000 description 1
- 235000003976 Ruta Nutrition 0.000 description 1
- 240000005746 Ruta graveolens Species 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 241000534017 Saururus chinensis Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000593775 Serissa Species 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- NTFQHAKUNDRGJR-UHFFFAOYSA-N Sophoradiol Natural products CC1(C)CC(O)C2(C)CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1 NTFQHAKUNDRGJR-UHFFFAOYSA-N 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000218989 Trichosanthes Species 0.000 description 1
- 235000004224 Typha angustifolia Nutrition 0.000 description 1
- 241001518821 Typha orientalis Species 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 235000000125 common agrimony Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000008384 ileus Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 239000010446 mirabilite Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 239000010773 plant oil Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000008986 qingzhen Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 235000005806 ruta Nutrition 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000000276 sedentary effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- ZEGUWBQDYDXBNS-FVFJQADASA-N sophoradiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)[C@H](O)CC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C ZEGUWBQDYDXBNS-FVFJQADASA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 201000003875 tinea corporis Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000008689 wuhua Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种龙倍清消痔散,由以下重量份的原料制成:重楼10~35份、白芍10~35份、五倍子10~35份、槐花1~15份、龙骨5~20份、蒲黄1~15份、冰片0.5~5份、调和剂0.1~3份,还公开了其制备方法。本申请龙倍清消痔散能够在用药10~30min内就能够迅速止痛,并且能够快速止血,早上用药下午就能够止血,能够根治痔疮,在治疗痔疮方面具有治疗周期短、见效快、疗效好、治愈率高、铲除病根的效果,治疗过程无痛苦,减轻了患者的痛苦,且制备方法简单,操作简便。
Description
技术领域
本发明属于中药制剂技术领域,尤其涉及一种消痔散及其制备方法。
背景技术
痔,俗称痔疮,是临床上一种最常见的肛门疾病,是人体阴阳失调、脏腑气血虚损外加风寒燥热及情志内伤、饮食起居不节等因素,致使肛肠部血液循环不畅,血液回流障碍引起的静脉曲张,任何年龄都可能发病,但随着年龄增长,发病率逐渐增高。痔是最常见的肛肠疾病,素有“十男九痔”、“十女十痔”的说法。痔的诱发因素很多,其中便秘、长期饮酒、进食大量刺激性食物和久坐久立是主要诱因。英国人Thomson在1975年提出了痔的近代概念:痔是直肠下端的肛垫出现了病理性肥大。根据发生部位的不同,痔可分为内痔、外痔和混合痔。目前认为内痔(Internalhemorrhoid)是肛垫(肛管血管垫)的支持结构、血管丛及动静脉吻合支发生的病理性改变或移位。外痔(Externalhemorrhoid)是齿状线远侧皮下血管丛的病理性扩张或血栓形成。混合痔(Mixedhemorrhoid)是内痔和外痔混合体。痔疮的主要表现为便血,便血的性质可为无痛、间歇性、便后鲜血,便时滴血或手纸上带血,便秘、饮酒或进食刺激性食物后加重。
医者认为:外痔一般无症状,仅有轻微不适感觉。无痛性间断性便后出鲜血是内痔和混合痔的早期症状。病人常在便池中滴入鲜血或便纸上发现染血。重者为喷射状,内痔或混合痔发展到一定时期(第二、三期)即可脱出肛门外,轻者便后可自行回纳;重者需用手方能回纳。单纯性内痔无疼,嵌顿时疼痛剧烈。内痔晚期可引起瘙痒。祖国医学对痔的病因病机早有认识,《内经》云“因而饱食,筋脉横解,肠癖为痔”的论述。《丹溪心法》云:“痔者皆因脏腑本虚,外伤风湿,内蕴热毒,以致气血下堕,结聚肛门,宿滞不散,而冲突为痔也。”《医宗金鉴》也云:“痔疮形名亦多般,不外风湿燥热源。”指出脏腑虚弱是痔病发生的基本因素,感受风湿燥热邪气是痔病发生的重要原因。同时,历代医家均认为痔是血管经脉病变。如《外科止宗》云:“气血纵横,经脉交错,……浊气疲血。流注肛门,俱能发痔。”明确提出血瘀是痔的病理机制。因此,中医认为,痔疮多是由于湿热蕴结、气血瘀滞于直肠肛门而致。现代研究多认为本病与直肠内压和肛管压增高、便秘、排便时间过长以及炎症有关。
痔疮便血的特点是间接性,一般见于大便秘结时,因粪便擦破粘膜或排粪用力猛,导致扩张血管破裂出血。血色鲜红,或多或少,有的为大便表面附血,有的擦屁股时纸上带血,有的点滴而下,有的如箭喷射,一般没有疼痛或其他不适。便血数日可自行停止。
痔疮虽然不会致命,却是一种令人非常痛苦且非常常见的病症。只有肛垫组织发生异常并合并有症状时,才需要治疗,治疗目的是解除症状,而非消除痔体。现有主要采用手术治疗和药物治疗的手段,两种治疗方法虽然都有一定缓解效果,但难以根治痔疮;其中,手术治疗不仅手术时疼痛,而且手术后还要长期注意保养,给患者带来不便。目前,西医对于药物治疗痔疮一直没有非常好的手段,有因复发多次手术造成瘘管,治标不治本,给病人造成极大的痛苦。
目前,市面上关于消痔的药物有一些文献报道,例如:
专利申请CN201710411867.X,公开了一种治疗痔疮的中药组合物,它包含下列重量份的物质:生地10-30份、元参20-50份、金银花20-30份、马齿苋10-30份、白芍20-30份、地丁草10-20份、生白术10-30份、蒲公英10-20份、三白草1-10份、川芎10-30份、天花粉10-20份、皂角刺10-20份、大蓟10-20份、水杨梅根5-20份、侧柏叶10-20份、甘草15-30份、陈皮20-30份、仙鹤草10-20份和白芷10-30份。本发明所述的中药组合物互相影响,协同作用,共同起到收敛固脱止血、消肿止痛及清热解毒的功效,疗效显著,非常值得大力推广。该专利疗效好,但是需要连续涂药一周以上才见效,治疗时间比较长,而且治标不治本,给病人造成极大的痛苦。
专利申请CN201510985244.4,公开了一种治疗痔疮的药物及其制备方法,其主要是由槐花、当归、金银花、皂角刺、黄连、蒲公英、黄芪、地榆、泽泻、红花、甘草、灯心草、连翘、苍术、浙贝母、枳壳、生地黄、槟榔、羌活、肉苁蓉、刘寄奴、白芷、茶叶、赤芍、牡丹皮、川芎按一定重量配比制备而成。本发明药物具有补肾益精,补血和血,顺气导滞,清热排毒,润燥滑肠,益卫固表,健脾的功能,用于治疗痔疮见效快、疗效好,不复发。该专利疗效好,但是需要连续涂药两周以上才见效,治疗时间比较长,而且其制备方法较为复杂。
因此,研制出一种消痔散及其制备方法尤为重要。
发明内容
本发明为解决上述技术问题,提供了一种消痔散及其制备方法。本申请消痔散能够在用药10~30min内就能够迅速止痛,并且能够快速止血,早上用药下午就能够止血,能够根治痔疮,在治疗痔疮方面具有治疗周期短、见效快、疗效好、治愈率高、铲除病根的效果,治疗过程无痛苦,减轻了患者的痛苦,且制备方法简单,操作简便。
为了能够达到上述所述目的,本发明采用以下技术方案:
一种消痔散,由以下重量份的原料制成:重楼10~35份、白芍10~35份、五倍子10~35份、槐花1~15份、龙骨5~20份、蒲黄1~15份、冰片0.5~5份、调和剂0.1~3份。
进一步地,所述的一种消痔散,由以下重量份的原料制成:重楼15~30份、白芍15~30份、五倍子15~30份、槐花5~10份、龙骨10~15份、蒲黄5~10份、冰片1~4份、调和剂0.5~2.5份。
进一步地,所述的一种消痔散,由以下重量份的原料制成:重楼20份、白芍20份、五倍子20份槐花5份、龙骨10份、蒲黄5份、冰片2份、调和剂1份。
进一步地,所述调和剂为茶油或鸡蛋清。
进一步地,一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
进一步地,在步骤(1),所述萎凋处理的温度为28~33℃,时间为10~15h。
进一步地,在步骤(2),所述晾晒的时间为3~4h,光照强度为2000~2300Lux,晾晒过程中每隔40~50min翻动一次。
进一步地,在步骤(2),所述烘干的温度为70~80℃,烘干时间为6~8h,烘干至原料含水量为10~15%。
进一步地,在步骤(2),所述研磨是将物料研磨至过50~80目筛,研磨时间为5~7h。
进一步地,在步骤(2),所述混合粉末的目粒度为1000~1200目。
本申请所以各个原料的功效如下:
重楼:中药名,为百合科植物云南重楼或七叶一枝花的干燥根茎。其味苦,性微寒;有小毒。有清热解毒,消肿止痛,凉肝定惊之功效,常用于疔疮痈肿,咽喉肿痛,蛇虫咬伤,跌扑伤痛,惊风抽搐。
白芍:白芍是毛茛科白芍属植物,是毛莨科植物芍药的干燥根。夏、秋二季采挖,洗净,除去头尾和细根,置沸水中煮后除去外皮或去皮后再煮,晒干。归肝、脾、肺三经。具有平肝止痛,养血调经,敛阴止汗的功效。用于头痛眩晕,胁痛,腹痛,四肢挛痛,血虚萎黄,月经不调,自汗,盗汗。
五倍子:五倍子学名(Rhus chinensis Mill.),又名百虫仓、百药煎、棓子,为同翅目蚜虫科的角倍蚜或倍蛋蚜雌虫寄生于漆树科植物“盐肤木”及其同属其他植物的嫩叶或叶柄,刺伤而生成一种囊状聚生物虫瘿,经烘焙干燥后所得。此外,五倍子还是一种药材,可以治疗多种疾病。其性寒,味酸、涩,具有敛肺降火、涩肠止泻、敛汗止血、收湿敛疮等功效,主治肺虚久咳、久泻久痢、便血痔血、痈肿疮毒、皮肤湿烂等症。
槐花:又名洋槐花,广义的洋槐花指豆科植物的花及花蕾,但一般将开放的花朵称为“槐花”,也称“槐蕊”,花蕾则称为“槐米”。洋槐花具有良好的观赏价值,每到花期来临时,一串串洁白的槐花缀满树枝,空气中弥漫着淡淡的素雅的清香,沁人心脾。古代中土与槐花有关的诗歌,比如:“袅袅秋风多,槐花半成实”(白居易《秋日》),“风舞槐花落御沟,终南山色入城秋”(子兰《长安早秋》,这些诗歌歌咏的是中国本地物种国槐,而非洋槐或者刺槐。中医认为其味苦、性微寒,归肝、大肠经;入血敛降,体轻微散;具有凉血止血、清肝泻火、降压的功效;对吐血、尿血、痔疮出血、风热目赤、高血压病、高脂血症、颈淋巴结核、血管硬化、大便带血、糖尿病、视网膜炎、银屑病等有显著疗效;还可以驱虫、治咽炎;槐花能增强毛细血管的抵抗力,减少血管通透性,可使脆性血管恢复弹性的功能,从而降血脂和防止血管硬化。而从西医的角度看,槐花含芦丁(即芸香苷,Rytub)、槲皮素(Quercetin)、鞣质、槐花二醇(sophoradiol)、维生素A等物质(具体可参见下面的含量表)。芦丁能改善毛细血管的功能,保持毛细血管正常的抵抗力,防止因毛细血管脆性过大,渗透性过高引起的出血、高血压、糖尿病,服之可预防出血。所以槐花多作为为治疗便血的常用药,用于大肠湿热引起的痔出血、便血、血痢及血热引起的吐血、衄血。
龙骨:别名陆虎遗生、那伽骨、生龙骨、煅龙骨、五花龙骨、青化龙骨、花龙骨、白龙骨。为古代哺乳动物如象类、犀牛类、三趾马等的骨胳的化石。味甘平,性涩,无毒;入心、肝、肾、大肠经。主治重镇安神,镇惊安神,敛汗固精,止血涩肠,生肌敛疮,平肝潜阳,固涩,收敛。治惊痫癫狂,心悸怔忡,怔忡健忘,失眠多梦,头晕目眩,自汗盗汗,遗精淋浊,吐衄便血,崩漏带下,泻痢脱肛,久泻久痢,溃疡久不收口及湿疮。
蒲黄:中药名。为香蒲科植物水烛香蒲Typha angustifolia L.、东方香蒲Typhaorientalis Presl或同属植物的干燥花粉。夏季采收蒲棒上部的黄色雄花序,晒干后碾轧,筛取花粉。剪取雄花后,晒干,成为带有雄花的花粉,即为草蒲黄。味甘,性平。归肝、心包经;具有止血,化瘀,通淋的功效;主治吐血,衄血,咯血,崩漏,外伤出血,经闭通经,胸腹刺痛,跌扑肿痛,血淋涩痛。
冰片,又名片脑、桔片、艾片、龙脑香、梅花冰片、羯布罗香、梅花脑、冰片脑、梅冰等,是由菊科艾纳香茎叶或樟科植物龙脑樟枝叶经水蒸汽蒸馏并重结晶而得。亦有用松节油经一系列化学方法工艺而得。其可用于闭证神昏、用于目赤肿痛,喉痹口疮、用于疮疡肿痛,溃后不敛等。《本草经疏》:“凡中风非外来之风邪,乃因气血虚而病者忌之;小儿吐泻后成惊者为慢脾风,急惊属实热可用,慢惊属虚寒不可用;眼目昏暗属肝肾虚者不宜入点药。”。味辛、苦,微寒;归心、脾,肺经;清香宣散,具有开窍醒神,清热散毒,明目退翳的功效,主治热病高热神昏,中风痰厥惊痫,暑湿蒙蔽清窍,喉痹耳聋,口疮齿肿,疮痈疳痔,目赤肿痛,翳膜遮睛。凡痰火郁闭,喉痹音哑,或火热壅滞,口疮齿肿者,冰片可与朱砂、硼砂、玄明粉配伍吹搽患处,以散火解毒;热闭神昏者,冰片可与麝香、牛黄、黄连、郁金等配伍,以清热开窍;暴发火眼,或翳膜胬肉者,冰片可与炉甘石、玄明粉、硼砂配伍,为末点眼。
茶油:油茶籽油俗称,又名山茶油、山茶籽油,是从山茶科山茶属植物的普通油茶(Camellia oleiferaAbel)成熟种子中提取的纯天然高级食用植物油,色泽金黄或浅黄,品质纯净,澄清透明,气味清香,味道纯正。油茶与茶叶(学名Camellia sinensis(L.)O.Kuntze)为同属不同种,它们所结的种子榨出的植物油是完全不同的,前者称为油茶籽油,后者称为茶叶籽油。全球油茶籽油产量的90%以上来自中国。茶油是中国政府提倡推广的纯天然木本食用植物油,以及国际粮农组织首推的卫生保健植物食用油。归大肠经;具有清热解毒、润肠、杀虫的功效;主治痧气腹痛;便秘;蛔虫腹痛;蛔虫性肠梗阻;疥癣;汤火伤。茶油能抗紫外线,直接搽用有防止晒斑及去皱、防止头癣、体癣、头屑、脱发的功效。茶油可做洗发剂和护法素中的配剂使用,能防止皮肤瘙痒、慢性湿疹。
鸡蛋清:也被称为“蛋白”或“蛋清”,是鸡蛋里围绕蛋黄的透明液体部分。蛋清起初是单细胞卵子细胞质,其目的是给发育中的胚胎提供营养。这也是蛋白富含营养,并可以作为理想营养滋补品的原因所在。味甘,性凉;主治治咽痛,目赤,咳逆,下肉,疟疾,烧伤,热毒肿痛。
本申请消痔散的使用方法为:将药物塞入患有内痔、外痔或混合痔患者的肛门。
由于本发明采用了以上技术方案,具有以下有益效果:
(1)本申请消痔散能够在用药10~30min内就能够迅速止痛,并且能够快速止血,早上用药下午就能够止血,能够根治痔疮,在治疗痔疮方面具有治疗周期短、见效快、疗效好、治愈率高、铲除病根的效果,治疗过程无痛苦,减轻了患者的痛苦,且制备方法简单,操作简便。
(2)本申请消痔散具有清热除湿、消肿止痛、凉血止血、化瘀润燥、润肠通便、固脱收缩痔核、净化肛内环境等功能,可有效治疗内痔、外痔和混合痔,可有效治疗大便前后岀血、疼痛肿胀、肛门湿疹或瘙痒等症状。
(3)本申请配方遵循君臣佐使的原则,以重楼、白芍、五倍子作为君药;以槐花、龙骨、蒲黄作为臣药;以冰片作为佐药;以调和剂鸡蛋清或茶油作为使药;在原料中加入了调和剂茶油,茶油本身具有清热、消炎、止痒的作用,能够调和诸药,各个原料之间相辅相成,达到治疗痔疮的目的。
具体实施方式
下面对本发明的具体实施方式作进一步详细的说明,但本发明并不局限于这些实施方式,任何在本实施例基本精神上的改进或代替,仍属于本发明权利要求所要求保护的范围。
实施例1
一种消痔散,由以下重量份的原料制成:重楼10份、白芍10份、五倍子10份、槐花1份、龙骨5份、蒲黄1份、冰片0.5份、调和剂0.1份。进一步地,所述调和剂为茶油。
一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;所述萎凋处理的温度为28℃,时间为10h;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
所述晾晒的时间为3h,光照强度为2000Lux,晾晒过程中每隔40min翻动一次;所述烘干的温度为70℃,烘干时间为6h,烘干至原料含水量为10%;所述研磨是将物料研磨至过50目筛,研磨时间为5h;所述混合粉末的目粒度为1000目;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
凌某某,女,72岁,贵州省贵阳市清镇人,患内痔十余年,经医院做手术两次,半年后又复发,复发时伴有便血、肛门疼痛,采用本实施例制得的消痔散进行治疗后痊愈。
实施例2
一种消痔散,由以下重量份的原料制成:重楼35份、白芍35份、五倍子35份、槐花15份、龙骨20份、蒲黄15份、冰片5份、调和剂3份。进一步地,所述调和剂为鸡蛋清。
一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;所述萎凋处理的温度为33℃,时间为15h;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
所述晾晒的时间为4h,光照强度为2300Lux,晾晒过程中每隔50min翻动一次;所述烘干的温度为80℃,烘干时间为8h,烘干至原料含水量为15%;所述研磨是将物料研磨至过80目筛,研磨时间为7h;所述混合粉末的目粒度为1200目;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
许某,女,65岁,贵州省凯里市榕江县人,患混合痔八年,经医院做手术三次,半年后又复发,采用本实施例制得的消痔散进行治疗后痊愈。
实施例3
一种消痔散,由以下重量份的原料制成:重楼15份、白芍15份、五倍子15份、槐花5份、龙骨10份、蒲黄5份、冰片1份、调和剂0.5份。进一步地,所述调和剂为茶油。
一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;所述萎凋处理的温度为29℃,时间为11h;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
所述晾晒的时间为3.2h,光照强度为2100Lux,晾晒过程中每隔42min翻动一次;所述烘干的温度为72℃,烘干时间为6.5h,烘干至原料含水量为10~15%;所述研磨是将物料研磨至过60目筛,研磨时间为5.5h;所述混合粉末的目粒度为1050目;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
陈某某,男,68岁,贵州省都匀人,患混合痔十三年,经医院做手术两次,半年后又复发,采用本实施例制得的消痔散进行治疗后痊愈。
实施例4
一种消痔散,由以下重量份的原料制成:重楼30份、白芍30份、五倍子30份、槐花10份、龙骨15份、蒲黄10份、冰片4份、调和剂2.5份。进一步地,所述调和剂为鸡蛋清。
一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;所述萎凋处理的温度为32℃,时间为14h;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
所述晾晒的时间为3.9h,光照强度为2200Lux,晾晒过程中每隔49min翻动一次;所述烘干的温度为79℃,烘干时间为7.5h,烘干至原料含水量为14%;所述研磨是将物料研磨至过70目筛,研磨时间为6.5h;所述混合粉末的目粒度为1150目;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
毛某某,女,53岁,贵州省剑河人,患外痔十余年,经多方就医治疗效果欠佳,采用本实施例制得的消痔散进行治疗后痊愈。
实施例5
一种消痔散,由以下重量份的原料制成:重楼20份、白芍20份、五倍子20份、槐花5份、龙骨10份、蒲黄5份、冰片2份、调和剂1份。进一步地,所述调和剂为茶油或鸡蛋清。
一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;所述萎凋处理的温度为30℃,时间为12h;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
所述晾晒的时间为3.5h,光照强度为2150Lux,晾晒过程中每隔45min翻动一次;所述烘干的温度为75℃,烘干时间为7h,烘干至原料含水量为12%;所述研磨是将物料研磨至过65目筛,研磨时间为6h;所述混合粉末的目粒度为1100目;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
朱某某,女,66岁,贵州省丹寨人,患内痔九年,经多方就医治疗效果欠佳,采用本实施例制得的消痔散进行治疗后痊愈。
实施例6
一种消痔散,由以下重量份的原料制成:重楼20份、白芍20份、五倍子20份、槐花3份、龙骨7份、蒲黄3份、冰片1.5份、调和剂1份。进一步地,所述调和剂为鸡蛋清。
一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;所述萎凋处理的温度为30℃,时间为12h;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
所述晾晒的时间为3.3h,光照强度为2100Lux,晾晒过程中每隔43min翻动一次;所述烘干的温度为73℃,烘干时间为6.3h,烘干至原料含水量为12%;所述研磨是将物料研磨至过60目筛,研磨时间为5.3h;所述混合粉末的目粒度为1100目;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
蒙某某,男,78岁,贵州省贵阳市人,患内痔十五年,经多方就医治疗效果欠佳,采用本实施例制得的消痔散进行治疗后痊愈。
实施例7
一种消痔散,由以下重量份的原料制成:重楼25份、白芍25份、五倍子25份、槐花12份、龙骨18份、蒲黄12份、冰片4.5份、调和剂2份。进一步地,所述调和剂为茶油。
一种如上述所述的消痔散的制备方法,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;所述萎凋处理的温度为31℃,时间为13h;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
所述晾晒的时间为3.7h,光照强度为2200Lux,晾晒过程中每隔47min翻动一次;所述烘干的温度为77℃,烘干时间为7.5h,烘干至原料含水量为13%;所述研磨是将物料研磨至过70目筛,研磨时间为6.5h;所述混合粉末的目粒度为1100目;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
赵某某,女,55岁,贵州省毕节人,患混合痔十余年,经多方就医治疗效果欠佳,采用本实施例制得的消痔散进行治疗后痊愈。
对比例1
按照专利申请CN201710411867.X中的实施例进行。
对比例2
按照专利申请CN201510985244.4中的实施例进行。
为了进一步说明本发明能够达到所述技术效果,做以下实验:
一、毒性试验
将小鼠的试验药物设定为高、中、低三个剂量,分别按人单位体重用药量的100倍、50倍和20倍的给药量为试验组,另设一正常饲养的对照组,连续给药三个月后,观察小鼠的各项生理、生化指标的变化情况。试验结果表明:该消痔散对小鼠的进食量和生长发育没有影响,对小鼠的肝功能和肾功能没有发现毒性作用,各组间与对照组相比无明显差异。
二、应用实例
选取患者270例,男135例,女135例,其中内痔患者90例,外痔患者90例,混合痔患者90例,年龄最小29岁,最大80岁,病程最短2个月,最长20年,有些患者接受过手术治疗但未治愈。
以上270例患者中,内痔、外痔和混合痔患者男女比例均相当,平均分为9组,每组30例患者,各组患者性别、年龄、病程、症状均无显著性差异,具有可比性(P>0.05)。
将本申请实施例1~7制得的消痔散用于治疗其中7组的患者,另外两组采用对比例1和对比例2制得的药物进行治疗,连续治疗3d。
疗效标准为:
①显效:用药后肛门症状消除或基本消除。嵌顿之内痔回缩及肛缘水肿、血栓肿块缩小程度≥2/3;
②有效:症状改善,脱出、嵌顿之内痔回缩及肛缘水肿和血栓肿块吸收达1/3~2/3;
③无效:症状无明显改善,脱出、嵌顿之内痔回缩及肛缘水肿、血栓肿块缩小<1/3。实验结果如下表1所示。
表1
组别 | 显效 | 有效 | 无效 | 总有效率/% |
实施例1 | 18 | 11 | 1 | 96.7 |
实施例2 | 17 | 11 | 2 | 93.3 |
实施例3 | 19 | 10 | 1 | 96.7 |
实施例4 | 18 | 11 | 1 | 96.7 |
实施例5 | 21 | 9 | 0 | 100 |
实施例6 | 17 | 12 | 1 | 96.7 |
实施例7 | 19 | 10 | 1 | 96.7 |
对比例1 | 0 | 10 | 20 | 33.3 |
对比例2 | 0 | 11 | 19 | 36.7 |
由表1实验数据可知,本申请制得的消痔散见效快、疗效显著,能在用药3d之内治愈痔疮,而对比例药物能够治疗痔疮,但是见效较慢,不能再3d之内治愈痔疮,治疗效果不显著。各组总有效率比较差异有统计学意义(P<0.05)。在治疗过程中观察,各组患者均未出现明显的不良反应。
综上所述,本申请消痔散能够在用药10~30min内就能够迅速止痛,并且能够快速止血,早上用药下午就能够止血,能够根治痔疮,在治疗痔疮方面具有治疗周期短、见效快、疗效好、治愈率高、铲除病根的效果,治疗过程无痛苦,减轻了患者的痛苦,且制备方法简单,操作简便。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在没有背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同腰间的含义和范围内的所有变化囊括在本发明的保护范围之内。
Claims (9)
1.一种消痔散,其特征在于,由以下重量份的原料制成:重楼10~35份、白芍10~35份、五倍子10~35份、槐花1~15份、龙骨5~20份、蒲黄1~15份、冰片0.5~5份、调和剂0.1~3份;
所述调和剂为茶油或鸡蛋清。
2.根据权利要求1所述的一种消痔散,其特征在于,由以下重量份的原料制成:重楼15~30份、白芍15~30份、五倍子15~30份、槐花5~10份、龙骨10~15份、蒲黄5~10份、冰片1~4份、调和剂0.5~2.5份。
3.根据权利要求1所述的一种消痔散,其特征在于,由以下重量份的原料制成:重楼20份、白芍20份、五倍子20份、槐花5份、龙骨10份、蒲黄5份、冰片2份、调和剂1份。
4.一种如权利要求1~3任一项所述的消痔散的制备方法,其特征在于,包括以下步骤:
(1)按照重量份数称取重楼、白芍、五倍子、槐花、龙骨和蒲黄,去杂、洗净、沥干表面水分后,摊晾萎凋处理;
(2)将萎凋处理好的原料置于阳光下晾晒,烘干,然后加入冰片,混合均匀后送入研磨机进行研磨,再送入超微粉碎机粉碎,得到混合粉末;
(3)将调和剂加入上述混合粉末中,搅拌均匀,得到所述消痔散。
5.根据权利要求4所述的一种消痔散的制备方法,其特征在于:在步骤(1),所述萎凋处理的温度为28~33℃,时间为10~15h。
6.根据权利要求4所述的一种消痔散的制备方法,其特征在于:在步骤(2),所述晾晒的时间为3~4h,光照强度为2000~2300Lux,晾晒过程中每隔40~50min翻动一次。
7.根据权利要求4所述的一种消痔散的制备方法,其特征在于:在步骤(2),所述烘干的温度为70~80℃,烘干时间为6~8h,烘干至原料含水量为10~15%。
8.根据权利要求4所述的一种消痔散的制备方法,其特征在于:在步骤(2),所述研磨是将物料研磨至过50~80目筛,研磨时间为5~7h。
9.根据权利要求4所述的一种消痔散的制备方法,其特征在于:在步骤(2),所述混合粉末的目粒度为1000~1200目。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811083037.XA CN109045186B (zh) | 2018-09-17 | 2018-09-17 | 一种消痔散及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811083037.XA CN109045186B (zh) | 2018-09-17 | 2018-09-17 | 一种消痔散及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109045186A CN109045186A (zh) | 2018-12-21 |
CN109045186B true CN109045186B (zh) | 2021-02-02 |
Family
ID=64762857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811083037.XA Active CN109045186B (zh) | 2018-09-17 | 2018-09-17 | 一种消痔散及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109045186B (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1425409A (zh) * | 2002-09-26 | 2003-06-25 | 夏义深 | 六神痔疮膏 |
CN101045104A (zh) * | 2007-04-24 | 2007-10-03 | 张秀丽 | 一种外用治疗痔疮的栓剂 |
CN105214207A (zh) * | 2015-10-24 | 2016-01-06 | 孙桂芝 | 一种风伤肠络型痔疮用栓塞给药器 |
CN107213264A (zh) * | 2017-04-28 | 2017-09-29 | 贵州益寿农业科技有限公司 | 一种治疗痔疮的外用膏药及其制作方法 |
-
2018
- 2018-09-17 CN CN201811083037.XA patent/CN109045186B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1425409A (zh) * | 2002-09-26 | 2003-06-25 | 夏义深 | 六神痔疮膏 |
CN101045104A (zh) * | 2007-04-24 | 2007-10-03 | 张秀丽 | 一种外用治疗痔疮的栓剂 |
CN105214207A (zh) * | 2015-10-24 | 2016-01-06 | 孙桂芝 | 一种风伤肠络型痔疮用栓塞给药器 |
CN107213264A (zh) * | 2017-04-28 | 2017-09-29 | 贵州益寿农业科技有限公司 | 一种治疗痔疮的外用膏药及其制作方法 |
Also Published As
Publication number | Publication date |
---|---|
CN109045186A (zh) | 2018-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103417904B (zh) | 一种治疗慢性唇炎的中药组合物及其制备方法 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
JP2005501851A (ja) | 毒素を除去するための組成物 | |
CN103690853B (zh) | 一种治疗湿烂型脚癣的中药制剂及其制备方法 | |
CN103432475B (zh) | 一种治疗过敏性鼻炎的中药组合物及其制备方法 | |
CN103638250B (zh) | 一种治疗面神经麻痹的中药制剂及其制备方法 | |
CN111617197A (zh) | 一种生发养发的中药组合物及其制备方法与应用 | |
CN104127813A (zh) | 一种治疗气血两虚型褥疮的中药组合物及其制备方法 | |
CN110898132A (zh) | 一种用于治疗痔疮的组合物及其应用 | |
CN104940886A (zh) | 一种治疗脂溢性脱发的外用制剂及制法 | |
CN104906430A (zh) | 一种治疗干眼症的中药制剂及其制备方法 | |
CN109045186B (zh) | 一种消痔散及其制备方法 | |
CN106729100A (zh) | 具有消炎、美容的外用中药保健制剂及其制备方法 | |
CN103099885A (zh) | 具有祛痤疮功能软胶囊及其制备方法 | |
CN104689283A (zh) | 一种治疗脾虚湿蕴型黄褐斑的药物及其制备方法 | |
CN105616536A (zh) | 一种治疗白癜风的中药擦剂 | |
CN104689125A (zh) | 一种治疗沙眼的药物及其制备方法 | |
CN104547758A (zh) | 一种治疗气虚血瘀型瘢痕疙瘩的药物及其制备方法 | |
CN104352866A (zh) | 一种治疗火毒伤津型烧伤的中药制剂及其制备方法 | |
CN104147480A (zh) | 一种止痛的外用中药组合物及其制备方法 | |
CN105079337A (zh) | 一种预防褥疮的护理液及其制备方法 | |
CN105998979A (zh) | 一种治疗肺肾阴虚型慢性咽炎的中药组合物及方法 | |
CN105795002A (zh) | 一种具有美容润肠功效的保健芝麻油及其制备方法 | |
CN106039075A (zh) | 一种治疗肺胃蕴热型慢性咽炎的中药组合物及方法 | |
CN105497817A (zh) | 一种用于踝关节外伤后肿胀的中药制剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |